MRSN Q3 2025 Earnings Results — Mersana Therapeutics, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Updated
When is MRSN's next earnings date?
Mersana Therapeutics, Inc. Common Stock (MRSN) has not announced its next earnings date yet. Its most recent earnings report was on Friday, November 14, 2025.
How did MRSN do in its last earnings report?
In its most recent report on Nov 14, 2025 (Q3 2025), Mersana Therapeutics, Inc. Common Stock posted EPS of -$1.51 versus the -$1.11 estimate, a miss of 36.0%. Revenue was $11.0M against a $13.9M estimate. The stock's 1-day post-earnings move was +1.8%.
How much does MRSN stock move after earnings?
MRSN beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 11.4% (up or down) in the day after earnings.
About Mersana Therapeutics, Inc. Common Stock
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-14 | Q3 2025 | -1.11 | -1.51 | -36.04% | $11.0M | ❌ Miss | +1.79% | +0.29% | +4.23% |
| 2025-08-13 | Q2 2025 | -4.05 | -4.08 | -0.74% | $3.1M | ❌ Miss | +12.19% | +19.28% | +23.06% |
| 2025-03-03 | Q4 2024 | -0.15 | -0.11 | +26.67% | $16.4M | ✅ Beat | -8.33% | +3.97% | -34.26% |
| 2024-11-13 | Q3 2024 | -0.17 | -0.09 | +47.06% | $12.6M | ✅ Beat | +19.55% | +0.91% | +4.55% |
| 2024-08-13 | Q2 2024 | -0.17 | -0.20 | -17.65% | $2.3M | ❌ Miss | -4.93% | -5.27% | +24.65% |
| 2024-05-09 | Q1 2024 | -0.18 | -0.16 | +11.11% | $9.2M | ✅ Beat | -27.51% | -24.41% | -37.06% |
| 2024-02-28 | Q4 2023 | -0.16 | -0.16 | +0.00% | $10.7M | ➖ Inline | +13.58% | +35.13% | +5.15% |
| 2023-11-07 | Q3 2023 | -0.36 | -0.35 | +2.78% | $7.7M | ✅ Beat | -3.60% | -10.07% | +56.83% |
Showing last 8 quarters.